<table id="i7e285610-d5d1-4492-8587-010ac313a0be" width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Effects on steady-state fexofenadine pharmacokinetics after 7 days of co-administration with fexofenadine hydrochloride 120 mg every 12 hours (two times the recommended twice daily dose) in healthy volunteers (n=24)</caption>
<col align="center" valign="top" width="33.3%"></col>
<col align="center" valign="top" width="33.3%"></col>
<col align="center" valign="top" width="33.4%"></col>
<thead>
<tr>
<th>
<content stylecode="italics">Concomitant Drug</content>
</th>
<th>
<content stylecode="italics">C<sub>max</sub>SS<br/>(Peak plasma concentration)</content>
</th>
<th>
<content stylecode="italics">AUC<sub>ss(0â€“12h)</sub>
<br/>(Extent of systemic exposure)</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Erythromycin<br/>(500 mg every 8 hrs)</td>
<td>+82%</td>
<td> +109%</td>
</tr>
<tr>
<td>Ketoconazole <br/>(400 mg once daily)</td>
<td>+135%</td>
<td> +164%</td>
</tr>
</tbody>
</table>